C-reactive protein (CRP) levels elevated prior to treatment or during the course of treatment, as well as cancer cachexia, hypoalbuminemia, anemia and weight loss, significantly impact the prognosis of cancer patients [7–9]. The gene discussed is CRP; the disease is Hypoalbuminemia.